Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Gehring

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Science Immunology|January 30, 2026
B cells drive CD4 T cell immunosenescence and age-associated health declineSaad Khan, Mainak Chakraborty, Fei Wu, et al.
European Journal of Immunology|May 30, 2024
Intrahepatic plasma cells, but not atypical memory B cells, associate with clinical phases of chronic hepatitis BZgjim Osmani, Martin Arreola Villanueva, Jasmin Joseph-Chazan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 3, 2025
HBV Suppression by Nucleos(t)ide Analogues Reduces PD-1 Expression on Liver-Resident T CellsMireia García-López, Sabela Lens, Laura J Pallett, et al.
Plos Pathogens|June 27, 2014
Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liverJuandy Jo, Anthony T Tan, James E Ussher, et al.
European Journal of Immunology|January 3, 2013
Conditional ligands for Asian HLA variants facilitate the definition of CD8+ T-cell responses in acute and chronic viral diseasesCynthia X L Chang, Anthony T Tan, Ming Yan Or, et al.
Plos One|July 23, 2014
A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearanceThomas H King, Charles B Kemmler, Zhimin Guo, et al.
The Journal of Infectious Diseases|July 21, 2021
The Inflammatory Cytokine Profile Associated With Liver Damage Is Broader and Stronger in Patients With Chronic Hepatitis B Compared to Patients With Acute Hepatitis BAlexandra Johnson Valiente, Kin Seng Liem, Kathleen B Schwarz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 16, 2025
Peginterferon λ for the treatment of patients admitted to hospital with COVID-19: a phase 2, placebo-controlled randomized trialChristopher Kandel, Mia J Biondi, Mark Gillrie, et al.
The Lancet. Gastroenterology & Hepatology|April 15, 2019
A global scientific strategy to cure hepatitis BPeter A Revill, Francis V Chisari, Joan M Block, et al.
Biorxiv : the Preprint Server for Biology|March 26, 2024
B Cells Promote T Cell Immunosenescence and Mammalian Aging ParametersSaad Khan, Mainak Chakraborty, Fei Wu, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Science Immunology|January 30, 2026
B cells drive CD4 T cell immunosenescence and age-associated health declineSaad Khan, Mainak Chakraborty, Fei Wu, et al.
European Journal of Immunology|May 30, 2024
Intrahepatic plasma cells, but not atypical memory B cells, associate with clinical phases of chronic hepatitis BZgjim Osmani, Martin Arreola Villanueva, Jasmin Joseph-Chazan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 3, 2025
HBV Suppression by Nucleos(t)ide Analogues Reduces PD-1 Expression on Liver-Resident T CellsMireia García-López, Sabela Lens, Laura J Pallett, et al.
Plos Pathogens|June 27, 2014
Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liverJuandy Jo, Anthony T Tan, James E Ussher, et al.
European Journal of Immunology|January 3, 2013
Conditional ligands for Asian HLA variants facilitate the definition of CD8+ T-cell responses in acute and chronic viral diseasesCynthia X L Chang, Anthony T Tan, Ming Yan Or, et al.
Plos One|July 23, 2014
A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearanceThomas H King, Charles B Kemmler, Zhimin Guo, et al.
The Journal of Infectious Diseases|July 21, 2021
The Inflammatory Cytokine Profile Associated With Liver Damage Is Broader and Stronger in Patients With Chronic Hepatitis B Compared to Patients With Acute Hepatitis BAlexandra Johnson Valiente, Kin Seng Liem, Kathleen B Schwarz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 16, 2025
Peginterferon λ for the treatment of patients admitted to hospital with COVID-19: a phase 2, placebo-controlled randomized trialChristopher Kandel, Mia J Biondi, Mark Gillrie, et al.
The Lancet. Gastroenterology & Hepatology|April 15, 2019
A global scientific strategy to cure hepatitis BPeter A Revill, Francis V Chisari, Joan M Block, et al.
Biorxiv : the Preprint Server for Biology|March 26, 2024
B Cells Promote T Cell Immunosenescence and Mammalian Aging ParametersSaad Khan, Mainak Chakraborty, Fei Wu, et al.
Pageof 9